IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 373 to 384 of 468
29 March 2011
IDPC Report - First IDPC seminar on drug policy in the Middle East and North Africa

IDPC Report - First IDPC seminar on drug policy in the Middle East and North Africa

Last January, IDPC organised its first drug policy seminar in the Middle East and North Africa region, in collaboration with its local partner, the National Rehabilitation Centre, in order to generate constructive discussions and sgare experience on drug policy, and to discuss the possibility to establish a regional network on drug policy.
28 March 2011
IDPC progress report 2010-2011

IDPC progress report 2010-2011

Since its creation in 2007, IDPC has become a dynamic collaborative initiative which has gradually expanded both its membership and activities to influence national and international drug policies and programmes. This is the first IDPC progress report, which aims to highlight IDPC's key activities and successes since its creation four years ago.
16 March 2011

IDPC Briefing Paper - The heroin shortage in the UK and Europe

In 2010, observers of the UK heroin scene noticed signs of disruption in the normally well-supplied and efficiently administered UK heroin market. IDPC has been monitoring the situation closely, both in the UK and continental Europe. This briefing paper provides an overview of the European situation, describes the responses of authorities and users, and analyses its possible causes and future development.
23 February 2011

Drug policy: Lessons learned and options for the future

This paper examines why the vision of the architects of the global prohibition regime has not been achieved, but also goes on to describe the damage to human health and welfare that has arisen from badly conceived and implemented drug control policies and programmes. The concluding section lays out the broad options that policy makers face for a future ‘direction of travel’.